As the COVID-19 pandemic spread around the world, the importance of the biotech sector suddenly became very clear to everyone. Things we have taken for granted for our entire lives—ready access to vaccines and medicine—became a scarce commodity, and the supply chains to deliver them became a top priority.

But the biotech sector is far larger than just vaccines (or even pharmaceuticals). Biotech companies in Canada are working on products for customers in agriculture, manufacturing, and more. On this episode of Free Lunch, Andrew Casey joins us to explain how the biotech sector works, who the key players are, and preview some of the big innovations in the space.

Andrew is the President & CEO of BIOTECanada, Canada's national biotechnology industry association.

-----

Links:

Why Biotech Is Way Bigger Than Vaccines